Respiratory Research Reports & Consulting

Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 May 13
Pneumothorax Treatment Market Size, Share, Industry, Forecast and outlook (2026-2033)
The global pneumothorax treatment market was valued at USD 1.48 billion in 2025 and is projected to reach nearly USD 2.36 billion by 2033, growing at a CAGR of 6.8% during the forecast period from 2026 to 2033.
Starting from
$4350$3480
Published: 2026 April 15
Bronchitis Treatment Market Size, Forecast and outlook (2026-2033)
Bronchiolitis Treatment Market valued at US$ 7.21 billion in 2025, projected to reach US$ 10.88 billion by 2033, growing at a CAGR of 5.27% during 2026–2033.
Starting from
$4350$3480
Published: 2026 May 14
Pediatric Asthma Treatment Market Size, Share, Industry, Forecast and outlook (2026-2033)
The global pediatric asthma treatment market was valued at USD 6.54 billion in 2025 and is projected to reach nearly USD 12.22 billion by 2033, growing at a CAGR of 7.8% during the forecast period from 2026 to 2033.
Starting from
$4350$3480
Published: 2024 October 14
Bronchial Spasm Market Size, Share, Industry, Forecast and outlook (2024-2031)
Global Bronchial Spasm Market reached US$ 424.36 million in 2023 and is expected to reach US$ 650.05 million by 2031
Starting from
$4350$3480
Published: 2024 December 26
Respules Market Size, Share, Industry, Forecast and outlook (2024-2031)
The Respules Market is expected to grow at a CAGR of 6.1% during the forecast period 2024-2031 | DataM Intelligence Market Research
Starting from
$4350$3480
Published: 2024 November 19
Erdosteine Market Size, Share, Industry, Forecast and outlook (2024-2031)
Erdosteine Market is expected to grow at a high CAGR during the forecast period 2023-2030 | DataM Intelligence
Starting from
$4350$3480
Published: 2024 June 24
Asthma and COPD Drug Market Size, Share, Industry, Forecast and outlook (2024-2031)
Asthma and COPD Drug Market is expected to grow at a CAGR of 3.9% during the forecast period 2024-2031
Starting from
$4350$3480
Published: 2025 August 19
Global Pulmonary Drugs Market Trends, Growth Opportunities & Competitive Insights (2024–2031)
Discover the global pulmonary drugs market outlook (2024–2031) with a CAGR of 4.8%. Explore key drivers, challenges, COVID-19 impact, leading companies, regional insights, and opportunities in asthma & COPD treatments.
Starting from
$4350$3480